Amy Finkelstein
Names
| first: |
Amy |
| last: |
Finkelstein |
Identifer
Contact
Affiliations
-
Massachusetts Institute of Technology (MIT)
/ Economics Department
Research profile
author of:
- How General Are Risk Preferences? Choices under Uncertainty in Different Domains (RePEc:aea:aecrev:v:102:y:2012:i:6:p:2606-38)
by Liran Einav & Amy Finkelstein & Iuliana Pascu & Mark R. Cullen - Selection on Moral Hazard in Health Insurance (RePEc:aea:aecrev:v:103:y:2013:i:1:p:178-219)
by Liran Einav & Amy Finkelstein & Stephen P. Ryan & Paul Schrimpf & Mark R. Cullen - The Impact of Medicaid on Labor Market Activity and Program Participation: Evidence from the Oregon Health Insurance Experiment (RePEc:aea:aecrev:v:104:y:2014:i:5:p:322-28)
by Katherine Baicker & Amy Finkelstein & Jae Song & Sarah Taubman - Dynamic Inefficiencies in Insurance Markets: Evidence from Long-Term Care Insurance (RePEc:aea:aecrev:v:95:y:2005:i:2:p:224-228)
by Amy Finkelstein & Kathleen McGarry & Amir Sufi - Did Medicare Induce Pharmaceutical Innovation? (RePEc:aea:aecrev:v:96:y:2006:i:2:p:103-107)
by Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn - Multiple Dimensions of Private Information: Evidence from the Long-Term Care Insurance Market (RePEc:aea:aecrev:v:96:y:2006:i:4:p:938-958)
by Amy Finkelstein & Kathleen McGarry - Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance (RePEc:aea:aecrev:v:98:y:2008:i:2:p:157-62)
by David M. Cutler & Amy Finkelstein & Kathleen McGarry - The Interaction of Public and Private Insurance: Medicaid and the Long-Term Care Insurance Market (RePEc:aea:aecrev:v:98:y:2008:i:3:p:1083-1102)
by Jeffrey R. Brown & Amy Finkelstein - Approaches to Estimating the Health State Dependence of the Utility Function (RePEc:aea:aecrev:v:99:y:2009:i:2:p:116-21)
by Amy Finkelstein & Erzo F. P. Luttmer & Matthew J. Notowidigdo - Selection in Insurance Markets: Theory and Empirics in Pictures (RePEc:aea:jecper:v:25:y:2011:i:1:p:115-38)
by Liran Einav & Amy Finkelstein - Insuring Long-Term Care in the United States (RePEc:aea:jecper:v:25:y:2011:i:4:p:119-42)
by Jeffrey R. Brown & Amy Finkelstein - The RAND Health Insurance Experiment, Three Decades Later (RePEc:aea:jecper:v:27:y:2013:i:1:p:197-222)
by Aviva Aron-Dine & Liran Einav & Amy Finkelstein - Beyond Testing: Empirical Models of Insurance Markets (RePEc:anr:reveco:v:2:y:2010:p:311-336)
by Liran Einav & Amy Finkelstein & Jonathan Levin - What Good Is Wealth Without Health? The Effect Of Health On The Marginal Utility Of Consumption (RePEc:bla:jeurec:v:11:y:2013:i::p:221-258)
by Amy Finkelstein & Erzo F. P. Luttmer & Matthew J. Notowidigdo - Testing for Asymmetric Information Using “Unused Observables” in Insurance Markets: Evidence from the U.K. Annuity Market (RePEc:bla:jrinsu:v:81:y:2014:i:4:p:709-734)
by Amy Finkelstein & James Poterba - Unknown item RePEc:cdl:econwp:qt90g407hf (paper)
- Income and Health Spending: Evidence from Oil Price Shocks (RePEc:cpr:ceprdp:7255)
by Acemoglu, Daron & Finkelstein, Amy & Notowidigdo, Matthew J. - Selection Effects in the United Kingdom Individual Annuities Market (RePEc:ecj:econjl:v:112:y:2002:i:476:p:28-50)
by Amy Finkelstein & James Poterba - What Good Is Wealth without Health? The Effect of Health on the Marginal Utility of Consumption (RePEc:ecl:harjfk:rwp08-036)
by Finkelstein, Amy & Luttmer, Erzo F. P. & Notowidigdo, Matthew J. - Approaches to Estimating the Health State Dependence of the Utility Function (RePEc:ecl:harjfk:rwp09-002)
by Finkelstein, Amy N. & Luttmer, Erzo F. P. & Notowidigdo, Matthew J. - The Oregon Health Insurance Experiment: Evidence from the First Year (RePEc:ecl:harjfk:rwp11-040)
by Finkelstein, Amy, et al. - Optimal Mandates and the Welfare Cost of Asymmetric Information: Evidence From the U.K. Annuity Market (RePEc:ecm:emetrp:v:78:y:2010:i:3:p:1031-1092)
by Liran Einav & Amy Finkelstein & Paul Schrimpf - Redistribution by insurance market regulation: Analyzing a ban on gender-based retirement annuities (RePEc:eee:jfinec:v:91:y:2009:i:1:p:38-58)
by Finkelstein, Amy & Poterba, James & Rothschild, Casey - The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program (RePEc:eee:jhecon:v:23:y:2004:i:1:p:1-24)
by Finkelstein, Amy - The effect of tax subsidies to employer-provided supplementary health insurance: evidence from Canada (RePEc:eee:pubeco:v:84:y:2002:i:3:p:305-339)
by Finkelstein, Amy - Minimum standards, insurance regulation and adverse selection: evidence from the Medigap market (RePEc:eee:pubeco:v:88:y:2004:i:12:p:2515-2547)
by Finkelstein, Amy - Why is the market for long-term care insurance so small? (RePEc:eee:pubeco:v:91:y:2007:i:10:p:1967-1991)
by Brown, Jeffrey R. & Finkelstein, Amy - What did Medicare do? The initial impact of Medicare on mortality and out of pocket medical spending (RePEc:eee:pubeco:v:92:y:2008:i:7:p:1644-1668)
by Finkelstein, Amy & McKnight, Robin - Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance (RePEc:hrv:faseco:2640581)
by Cutler, David & McGarry, Kathleen & Finkelstein, Amy - Did Medicare Induce Pharmaceutical Innovation? (RePEc:hrv:faseco:2664267)
by Acemoglu, Daron & Finkelstein, Amy & Cutler, David & Linn, Joshua - Approaches to Estimating the Health State Dependence of the Utility Function (RePEc:iza:izadps:dp3925)
by Finkelstein, Amy & Luttmer, Erzo F.P. & Notowidigdo, Matthew J. - Medicaid Crowd-Out of Private Long-Term Care Insurance Demand: Evidence from the Health and Retirement Survey (RePEc:nbr:nberch:0045)
by Jeffrey R. Brown & Norma B. Coe & Amy Finkelstein - Comment on "The Demand for Medicare Part D Prescription Drug Coverage: Evidence from Four Waves of the Retirement Perspectives Survey" (RePEc:nbr:nberch:11939)
by Amy Finkelstein - Bunching at the Kink: Implications for Spending Responses to Health Insurance Contracts (RePEc:nbr:nberch:13814)
by Liran Einav & Amy Finkelstein & Paul Schrimpf - Why Is the Market or Long-term Care Insurance So Small? (RePEc:nbr:nberch:4361)
by Jeffrey R. Brown & Amy Finkelstein - Comment on "Mind the Gap! Consumer Perceptions and Choices of Medicare Part D Prescription Drug Plans" (RePEc:nbr:nberch:8215)
by Amy Finkelstein - Supply or Demand: Why is the Market for Long-Term Care Insurance So Small? (RePEc:nbr:nberwo:10782)
by Jeffrey R. Brown & Amy Finkelstein - The Interaction of Public and Private Insurance: Medicaid and the Long-Term Care Insurance Market (RePEc:nbr:nberwo:10989)
by Jeffrey R. Brown & Amy Finkelstein - Dynamic Inefficiencies in Insurance Markets: Evidence from long-term care insurance (RePEc:nbr:nberwo:11039)
by Amy Finkelstein & Kathleen McGarry & Amir Sufi - What Did Medicare Do (And Was It Worth It)? (RePEc:nbr:nberwo:11609)
by Amy Finkelstein & Robin McKnight - The Aggregate Effects of Health Insurance: Evidence from the Introduction of Medicare (RePEc:nbr:nberwo:11619)
by Amy Finkelstein - Did Medicare Induce Pharmaceutical Innovation? (RePEc:nbr:nberwo:11949)
by Daron Acemoglu & David Cutler & Amy Finkelstein & Joshua Linn - Testing for Asymmetric Information Using 'Unused Observables' in Insurance Markets: Evidence from the U.K. Annuity Market (RePEc:nbr:nberwo:12112)
by Amy Finkelstein & James Poterba - Redistribution by Insurance Market Regulation: Analyzing a Ban on Gender-Based Retirement Annuities (RePEc:nbr:nberwo:12205)
by Amy Finkelstein & James Poterba & Casey Rothschild - Input and Technology Choices in Regulated Industries: Evidence From the Health Care Sector (RePEc:nbr:nberwo:12254)
by Daron Acemoglu & Amy Finkelstein - Medicaid Crowd-Out of Private Long-Term Care Insurance Demand: Evidence from the Health and Retirement Survey (RePEc:nbr:nberwo:12536)
by Jeffrey R. Brown & Norma B. Coe & Amy Finkelstein - E-ZTax: Tax Salience and Tax Rates (RePEc:nbr:nberwo:12924)
by Amy Finkelstein - The Welfare Cost of Asymmetric Information: Evidence from the U.K. Annuity Market (RePEc:nbr:nberwo:13228)
by Liran Einav & Amy Finkelstein & Paul Schrimpf - Preference Heterogeneity and Insurance Markets: Explaining a Puzzle of Insurance (RePEc:nbr:nberwo:13746)
by David M. Cutler & Amy Finkelstein & Kathleen McGarry - What Good Is Wealth Without Health? The Effect of Health on the Marginal Utility of Consumption (RePEc:nbr:nberwo:14089)
by Amy Finkelstein & Erzo F.P. Luttmer & Matthew J. Notowidigdo - Estimating Welfare in Insurance Markets Using Variation in Prices (RePEc:nbr:nberwo:14414)
by Liran Einav & Amy Finkelstein & Mark R. Cullen - Income and Health Spending: Evidence from Oil Price Shocks (RePEc:nbr:nberwo:14744)
by Daron Acemoglu & Amy Finkelstein & Matthew J. Notowidigdo - Beyond Testing: Empirical Models of Insurance Markets (RePEc:nbr:nberwo:15241)
by Liran Einav & Amy Finkelstein & Jonathan Levin - How general are risk preferences? Choices under uncertainty in different domains (RePEc:nbr:nberwo:15686)
by Liran Einav & Amy Finkelstein & Iuliana Pascu & Mark R. Cullen - Selection in Insurance Markets: Theory and Empirics in Pictures (RePEc:nbr:nberwo:16723)
by Liran Einav & Amy Finkelstein - Selection on Moral Hazard in Health Insurance (RePEc:nbr:nberwo:16969)
by Liran Einav & Amy Finkelstein & Stephen P. Ryan & Paul Schrimpf & Mark R. Cullen - The Oregon Health Insurance Experiment: Evidence from the First Year (RePEc:nbr:nberwo:17190)
by Amy Finkelstein & Sarah Taubman & Bill Wright & Mira Bernstein & Jonathan Gruber & Joseph P. Newhouse & Heidi Allen & Katherine Baicker & The Oregon Health Study Group - Insuring Long Term Care In the US (RePEc:nbr:nberwo:17451)
by Jeffrey Brown & Amy Finkelstein - Moral Hazard in Health Insurance: How Important Is Forward Looking Behavior? (RePEc:nbr:nberwo:17802)
by Aviva Aron-Dine & Liran Einav & Amy Finkelstein & Mark R. Cullen - Social Insurance: Connecting Theory to Data (RePEc:nbr:nberwo:18433)
by Raj Chetty & Amy Finkelstein - The RAND Health Insurance Experiment, Three Decades Later (RePEc:nbr:nberwo:18642)
by Aviva Aron-Dine & Liran Einav & Amy Finkelstein - Healthcare Exceptionalism? Productivity and Allocation in the U.S. Healthcare Sector (RePEc:nbr:nberwo:19200)
by Amitabh Chandra & Amy Finkelstein & Adam Sacarny & Chad Syverson - The Response of Drug Expenditures to Non-Linear Contract Design: Evidence from Medicare Part D (RePEc:nbr:nberwo:19393)
by Liran Einav & Amy Finkelstein & Paul Schrimpf - The Impact of Medicaid on Labor Force Activity and Program Participation: Evidence from the Oregon Health Insurance Experiment (RePEc:nbr:nberwo:19547)
by Katherine Baicker & Amy Finkelstein & Jae Song & Sarah Taubman - Paying on the Margin for Medical Care: Evidence from Breast Cancer Treatments (RePEc:nbr:nberwo:20226)
by Liran Einav & Amy Finkelstein & Heidi Williams - Sources of Geographic Variation in Health Care: Evidence from Patient Migration (RePEc:nbr:nberwo:20789)
by Amy Finkelstein & Matthew Gentzkow & Heidi Williams - Beyond Statistics: The Economic Content of Risk Scores (RePEc:nbr:nberwo:21304)
by Liran Einav & Amy Finkelstein & Raymond Kluender & Paul Schrimpf - The Value of Medicaid: Interpreting Results from the Oregon Health Insurance Experiment (RePEc:nbr:nberwo:21308)
by Amy Finkelstein & Nathaniel Hendren & Erzo F.P. Luttmer - Healthcare Exceptionalism? Performance and Allocation in the U.S. Healthcare Sector (RePEc:nbr:nberwo:21603)
by Amitabh Chandra & Amy Finkelstein & Adam Sacarny & Chad Syverson - Private Provision of Social Insurance: Drug-specific Price Elasticities and Cost Sharing in Medicare Part D (RePEc:nbr:nberwo:22277)
by Liran Einav & Amy Finkelstein & Maria Polyakova - The Economic Consequences of Hospital Admissions (RePEc:nbr:nberwo:22288)
by Carlos Dobkin & Amy Finkelstein & Raymond Kluender & Matthew J. Notowidigdo - Bunching at the Kink: Implications for Spending Responses to Health Insurance Contracts (RePEc:nbr:nberwo:22369)
by Liran Einav & Amy Finkelstein & Paul Schrimpf - Is American Pet Health Care (Also) Uniquely Inefficient? (RePEc:nbr:nberwo:22669)
by Liran Einav & Amy Finkelstein & Atul Gupta - Healthcare Spending and Utilization in Public and Private Medicare (RePEc:nbr:nberwo:23090)
by Vilsa Curto & Liran Einav & Amy Finkelstein & Jonathan D. Levin & Jay Bhattacharya - Provider Incentives and Healthcare Costs: Evidence from Long-Term Care Hospitals (RePEc:nbr:nberwo:23100)
by Liran Einav & Amy Finkelstein & Neale Mahoney - Subsidizing Health Insurance for Low-Income Adults: Evidence from Massachusetts (RePEc:nbr:nberwo:23668)
by Amy Finkelstein & Nathaniel Hendren & Mark Shepard - What Does (Formal) Health Insurance Do, and For Whom? (RePEc:nbr:nberwo:23718)
by Amy Finkelstein & Neale Mahoney & Matthew J. Notowidigdo - Moral Hazard in Health Insurance: What We Know and How We Know It (RePEc:nbr:nberwo:24055)
by Liran Einav & Amy Finkelstein - Take-up and Targeting: Experimental Evidence from SNAP (RePEc:nbr:nberwo:24652)
by Amy Finkelstein & Matthew J. Notowidigdo - Long-Term Care Hospitals: A Case Study in Waste (RePEc:nbr:nberwo:24946)
by Liran Einav & Amy Finkelstein & Neale Mahoney - The Impact of Medicaid Expansion on Voter Participation: Evidence from the Oregon Health Insurance Experiment (RePEc:nbr:nberwo:25244)
by Katherine Baicker & Amy Finkelstein - Place-Based Drivers of Mortality: Evidence from Migration (RePEc:nbr:nberwo:25975)
by Amy Finkelstein & Matthew Gentzkow & Heidi L. Williams - Screening and Selection: The Case of Mammograms (RePEc:nbr:nberwo:26162)
by Liran Einav & Amy Finkelstein & Tamar Oostrom & Abigail J. Ostriker & Heidi L. Williams - The Challenges of Universal Health Insurance in Developing Countries: Evidence from a Large-scale Randomized Experiment in Indonesia (RePEc:nbr:nberwo:26204)
by Abhijit Banerjee & Amy Finkelstein & Rema Hanna & Benjamin A. Olken & Arianna Ornaghi & Sudarno Sumarto - Out of the Woodwork: Enrollment Spillovers in the Oregon Health Insurance Experiment (RePEc:nbr:nberwo:26871)
by Adam Sacarny & Katherine Baicker & Amy Finkelstein - In Praise of Moderation: Suggestions for the Scope and Use of Pre-Analysis Plans for RCTs in Economics (RePEc:nbr:nberwo:26993)
by Abhijit Banerjee & Esther Duflo & Amy Finkelstein & Lawrence F. Katz & Benjamin A. Olken & Anja Sautmann - Voluntary Regulation: Evidence from Medicare Payment Reform (RePEc:nbr:nberwo:27223)
by Liran Einav & Amy Finkelstein & Yunan Ji & Neale Mahoney - Welfare Analysis Meets Causal Inference (RePEc:nbr:nberwo:27640)
by Amy Finkelstein & Nathaniel Hendren - Why is End-of-Life Spending So High? Evidence from Cancer Patients (RePEc:nbr:nberwo:28162)
by Dan Zeltzer & Liran Einav & Amy Finkelstein & Tzvi Shir & Salomon M. Stemmer & Ran D. Balicer - The IO of Selection Markets (RePEc:nbr:nberwo:29039)
by Liran Einav & Amy Finkelstein & Neale Mahoney - A Taste of Their Own Medicine: Guideline Adherence and Access to Expertise (RePEc:nbr:nberwo:29356)
by Amy Finkelstein & Petra Persson & Maria Polyakova & Jesse M. Shapiro - Producing Health: Measuring Value Added of Nursing Homes (RePEc:nbr:nberwo:30228)
by Liran Einav & Amy Finkelstein & Neale Mahoney - What Drives Risky Prescription Opioid Use? Evidence from Migration (RePEc:nbr:nberwo:30471)
by Amy Finkelstein & Matthew Gentzkow & Dean Li & Heidi L. Williams - Heterogeneity in Damages from A Pandemic (RePEc:nbr:nberwo:30658)
by Amy Finkelstein & Geoffrey Kocks & Maria Polyakova & Victoria Udalova - Targeting Precision Medicine: Evidence from Prenatal Screening (RePEc:nbr:nberwo:30669)
by Peter Conner & Liran Einav & Amy Finkelstein & Petra Persson & Heidi L. Williams - The Health Wedge and Labor Market Inequality (RePEc:nbr:nberwo:31091)
by Amy Finkelstein & Casey C. McQuillan & Owen M. Zidar & Eric Zwick - Empirical Analyses of Selection and Welfare in Insurance Markets: A Self-Indulgent Survey (RePEc:nbr:nberwo:31146)
by Liran Einav & Amy Finkelstein - Geographic Variation in Healthcare Utilization: The Role of Physicians (RePEc:nbr:nberwo:31749)
by Ivan Badinski & Amy Finkelstein & Matthew Gentzkow & Peter Hull - Lives vs. Livelihoods: The Impact of the Great Recession on Mortality and Welfare (RePEc:nbr:nberwo:32110)
by Amy Finkelstein & Matthew J. Notowidigdo & Frank Schilbach & Jonathan Zhang - Market Design in Regulated Health Insurance Markets: Risk Adjustment vs. Subsidies (RePEc:nbr:nberwo:32586)
by Liran Einav & Amy Finkelstein & Pietro Tebaldi - The Effect of Medicaid on Crime: Evidence from the Oregon Health Insurance Experiment (RePEc:nbr:nberwo:33244)
by Amy Finkelstein & Sarah Miller & Katherine Baicker - The Impact of a Child with Down Syndrome (RePEc:nbr:nberwo:34064)
by Liran Einav & Amy Finkelstein & Petra Persson - Clinician Behavior When Skin-Tone Affects Test Results (RePEc:nbr:nberwo:34168)
by Marcella Alsan & Liran Einav & Amy Finkelstein & Jonathan Zhang - Racial Differences in Nursing Home Value Added (RePEc:nbr:nberwo:34324)
by Liran Einav & Amy Finkelstein & Neale Mahoney & James C. Okun - Selection Effects in the Market for Individual Annuities: New Evidence from the United Kingdom (RePEc:nbr:nberwo:7168)
by Amy Finkelstein & James Poterba - Adverse Selection in Insurance Markets: Policyholder Evidence from the U.K. Annuity Market (RePEc:nbr:nberwo:8045)
by Amy Finkelstein & James Poterba - Minimum Standards and Insurance Regulation: Evidence from the Medigap Market (RePEc:nbr:nberwo:8917)
by Amy Finkelstein - The Interaction of Partial Public Insurance Programs and Residual Private Insurance Markets: Evidence from the U.S. Medicare Program (RePEc:nbr:nberwo:9031)
by Amy Finkelstein - When Can Partial Public Insurance Produce Pareto Improvements? (RePEc:nbr:nberwo:9035)
by Amy Finkelstein - Health Policy and Technological Change: Evidence from the Vaccine Industry (RePEc:nbr:nberwo:9460)
by Amy Finkelstein - Private Information and its Effect on Market Equilibrium: New Evidence from Long-Term Care Insurance (RePEc:nbr:nberwo:9957)
by Amy Finkelstein & Kathleen McGarry - The Oregon Health Insurance Experiment: Evidence from the First Year (RePEc:oup:qjecon:v:127:y:2012:i:3:p:1057-1106)
by Amy Finkelstein & Sarah Taubman & Bill Wright & Mira Bernstein & Jonathan Gruber & Joseph P. Newhouse & Heidi Allen & Katherine Baicker - Estimating Welfare in Insurance Markets Using Variation in Prices (RePEc:sip:dpaper:08-006)
by Mark Cullen & Liran Einav & Amy Finkelstein - Estimating Welfare in Insurance Markets Using Variation in Prices (RePEc:sip:dpaper:08-046)
by Mark Cullen & Liran Einav & Amy Finkelstein - How General Are Risk Preferences? Choices Under Uncertainty in Different Domains (RePEc:sip:dpaper:09-005)
by Mark Cullen & Liran Einav & Amy Finkelstein & Iuliana Pascu - Selection in Insurance Markets: Theory and Emprirics in Pictures (RePEc:sip:dpaper:10-016)
by Liran Einav & Amy Finkelstein - Selection on Moral Hazard in Health Insurance (RePEc:sip:dpaper:10-028)
by Liran Einav & Amy Finkelstein & Stephen Ryan & Paul Schrimpf & Mark Cullen - Moral hazard in health insurance: How important is forward looking behavior? (RePEc:sip:dpaper:11-007)
by Aviva Aron-Dine & Liran Einav & Amy Finkelstein & Mark Cullen - The RAND Health Insurance Experiment, Three Decades Later (RePEc:sip:dpaper:12-007)
by Aviva Aron-Dine & Liran Einav & Amy Finkelstein - Paying on the margin for medical care: Evidence from breast cancer treatments (RePEc:sip:dpaper:13-034)
by Liran Einav & Amy Finkelstein & Heidi Williams - Income and Health Spending: Evidence from Oil Price Shocks (RePEc:tpr:restat:v:95:y:2013:i:4:p:1079-1095)
by Daron Acemoglu & Amy Finkelstein & Matthew J. Notowidigdo - Adverse Selection in Insurance Markets: Policyholder Evidence from the U.K. Annuity Market (RePEc:ucp:jpolec:v:112:y:2004:i:1:p:183-208)
by Amy Finkelstein & James Poterba - Input and Technology Choices in Regulated Industries: Evidence from the Health Care Sector (RePEc:ucp:jpolec:v:116:y:2008:i:5:p:837-880)
by Daron Acemoglu & Amy Finkelstein